BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15025615)

  • 1. The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury.
    Kvarnström A; Karlsten R; Quiding H; Gordh T
    Acta Anaesthesiol Scand; 2004 Apr; 48(4):498-506. PubMed ID: 15025615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibromyalgia--are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs.
    Sörensen J; Bengtsson A; Ahlner J; Henriksson KG; Ekselius L; Bengtsson M
    J Rheumatol; 1997 Aug; 24(8):1615-21. PubMed ID: 9263160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.
    Rabben T; Skjelbred P; Oye I
    J Pharmacol Exp Ther; 1999 May; 289(2):1060-6. PubMed ID: 10215688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans.
    Persson J; Hasselström J; Wiklund B; Heller A; Svensson JO; Gustafsson LL
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):750-8. PubMed ID: 9698948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy of intravenous lidocaine on various types of neuropathic pain].
    Nagaro T; Shimizu C; Inoue H; Fujitani T; Adachi N; Amakawa K; Kimura S; Arai T; Watanabe T; Oka S
    Masui; 1995 Jun; 44(6):862-7. PubMed ID: 7637167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate for treatment of chronic central pain after spinal cord injury. A double-blind cross-over study.
    Drewes AM; Andreasen A; Poulsen LH
    Paraplegia; 1994 Aug; 32(8):565-9. PubMed ID: 7970862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychometric changes as well as analgesic action and cardiovascular adverse effects of ketamine racemate versus s-(+)-ketamine in subanesthetic doses].
    Pfenninger E; Baier C; Claus S; Hege G
    Anaesthesist; 1994 Nov; 43 Suppl 2():S68-75. PubMed ID: 7840417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic effects of adenosine in syndrome X are counteracted by theophylline: a double-blind placebo-controlled study.
    Eriksson BE; Sadigh B; Svedenhag J; Sylvén C
    Clin Sci (Lond); 2000 Jan; 98(1):15-20. PubMed ID: 10600654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine.
    Sörensen J; Bengtsson A; Bäckman E; Henriksson KG; Bengtsson M
    Scand J Rheumatol; 1995; 24(6):360-5. PubMed ID: 8610220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effects on acute sensory thresholds and capsaicin-evoked hyperpathia.
    Wallace MS; Laitin S; Licht D; Yaksh TL
    Anesthesiology; 1997 Jun; 86(6):1262-72. PubMed ID: 9197294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic neurogenic facial pain: lack of response to intravenous phentolamine.
    Scrivani SJ; Chaudry A; Maciewicz RJ; Keith DA
    J Orofac Pain; 1999; 13(2):89-96. PubMed ID: 10425980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lidocaine tape relieves pain due to needle insertion during stellate ganglion block.
    Inada T; Uesugi F; Kawachi S; Inada K
    Can J Anaesth; 1997 Mar; 44(3):259-62. PubMed ID: 9067043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration-effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II.
    Wallace MS; Ridgeway BM; Leung AY; Gerayli A; Yaksh TL
    Anesthesiology; 2000 Jan; 92(1):75-83. PubMed ID: 10638902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous lignocaine in the management of primary fibromyalgia syndrome.
    Bennett MI; Tai YM
    Int J Clin Pharmacol Res; 1995; 15(3):115-9. PubMed ID: 8847152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of lidocaine in patients receiving palliative care with opioid-refractory cancer pain with a neuropathic component: study protocol for a randomized controlled study.
    Salas S; Auquier P; Duffaud F; Garnier SR; Deschamps M; Honoré S; Sudour P; Baumstarck K
    Trials; 2014 Aug; 15():318. PubMed ID: 25112302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of NMDA receptors in migraine: therapeutic and theoretic implications.
    Nicolodi M; Sicuteri F
    Int J Clin Pharmacol Res; 1995; 15(5-6):181-9. PubMed ID: 8835616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study.
    Attal N; Gaudé V; Brasseur L; Dupuy M; Guirimand F; Parker F; Bouhassira D
    Neurology; 2000 Feb; 54(3):564-74. PubMed ID: 10680784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of lidocaine tape for venous cannulation in children].
    Fukuda M; Takaki O; Nagata N; Satani M; Kitamura Y
    Masui; 1997 Jun; 46(6):793-7. PubMed ID: 9223883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interdisciplinary pain assessment of spinal cord injury patients.
    Quigley P; Veit N
    SCI Nurs; 1996 Sep; 13(3):62-8. PubMed ID: 8900667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-point discrimination thresholds in spinal cord injured patients with dysesthetic pain.
    Song ZK; Cohen MJ; Ament PA; Ho WH; Vulpe M; Schandler SL
    Paraplegia; 1993 Aug; 31(8):425-93. PubMed ID: 8414631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.